ARCT

Arcturus Therapeutics Holdings (ARCT)

About Arcturus Therapeutics Holdings (ARCT)

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Details

Daily high

$6.62

Daily low

$6.40

Price at open

$6.44

52 Week High

$24.17

52 Week Low

$5.85

Market cap

185.5M

Dividend yield

0.00%

Volume

1.7M

Avg. volume

799,734

P/E ratio

-2.65

Arcturus Therapeutics Holdings News